Randomised Trial of Eutectic Mixture of Local Anaesthetics Cream and Oral Sucrose Solution for Venepuncture
VIEP
1 other identifier
interventional
80
1 country
1
Brief Summary
This randomized bicentric trial will investigate the efficacy of topical EMLA cream with oral sucrose solution compared to oral sucrose solution alone before venepuncture in preterm infants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4 pain
Started Jun 2007
Shorter than P25 for phase_4 pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 4, 2007
CompletedFirst Posted
Study publicly available on registry
May 7, 2007
CompletedStudy Start
First participant enrolled
June 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2007
CompletedMay 4, 2011
May 1, 2007
5 months
May 4, 2007
May 3, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Association of oral sucrose solution and EMLA cream will reduce pain responses in premature infant for venepuncture.A combination of physiological and behavioural responses are used for the measurement of pain in neonates : DAN score and PIPP.
Association of oral sucrose solution and EMLA cream will reduce pain responses in premature infant for venepuncture.A combination of physiological and behavioural responses are used for the measurement of pain in neonates : DAN score and PIPP.
in 24 hours
Secondary Outcomes (1)
Clinical units providing health care in newborns develop written guidelines and protocols for the management of neonatal pain, like venepuncture with the combination of sucrose oral solution and EMLA cream.
in the 24 hours
Study Arms (1)
1
EXPERIMENTALvenepuncture
Interventions
Eligibility Criteria
You may qualify if:
- preterm infants (gestational age between 26 and 37 weeks)
- programmed venepuncture
- APGAR score (M5)≥ 7
- enteral feeding
- written parental consent
You may not qualify if:
- infant requiring oxygen
- analgesia or sedation or drugs causing methaemoglobinaemia
- congenital porphyria
- G6PD deficit
- multi organ failure
- convulsion
- dermatosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Armand Trousseau
Paris, 75012, France
Related Publications (2)
Acharya AB, Annamali S, Taub NA, Field D. Oral sucrose analgesia for preterm infant venepuncture. Arch Dis Child Fetal Neonatal Ed. 2004 Jan;89(1):F17-8. doi: 10.1136/fn.89.1.f17. No abstract available.
PMID: 14711847RESULTAcharya AB, Bustani PC, Phillips JD, Taub NA, Beattie RM. Randomised controlled trial of eutectic mixture of local anaesthetics cream for venepuncture in healthy preterm infants. Arch Dis Child Fetal Neonatal Ed. 1998 Mar;78(2):F138-42. doi: 10.1136/fn.78.2.f138.
PMID: 9577286RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Valérie BIRAN, MD
Assistance Publique - Hôpitaux de Paris
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 4, 2007
First Posted
May 7, 2007
Study Start
June 1, 2007
Primary Completion
November 1, 2007
Study Completion
November 1, 2007
Last Updated
May 4, 2011
Record last verified: 2007-05